share_log

Scotiabank Downgrades Syndax Pharmaceuticals to Sector Perform, Lowers Price Target to $23

Scotiabank Downgrades Syndax Pharmaceuticals to Sector Perform, Lowers Price Target to $23

丰业银行将Syndax Pharmicals的评级下调至行业表现,将目标股价下调至23美元
Benzinga ·  01/31 09:58

Scotiabank analyst George Farmer downgrades Syndax Pharmaceuticals (NASDAQ:SNDX) from Sector Outperform to Sector Perform and lowers the price target from $36 to $23.

丰业银行分析师乔治·法默将Syndax Pharmicals(纳斯达克股票代码:SNDX)的评级从板块跑赢大盘下调至板块表现,并将目标股价从36美元下调至23美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发